These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 84034)

  • 1. [3H]Uridine uptake by target monolayers as a terminal label in an in vitro cell-mediated cytotoxicity assay.
    Smith G; Nicklin S
    J Immunol Methods; 1979; 25(3):265-74. PubMed ID: 84034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A terminal labelling assay using 3H-uridine to measure cell-mediated cytotoxic responses against parainfluenza type 3 infected target cells.
    Williamson SI; Gibbins BL
    J Virol Methods; 1981 Mar; 2(4):237-47. PubMed ID: 6262347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vitro assay of cell-mediated cytotoxicity. Terminal labeling with 3h-leucine.
    Schechter B; Feldman M
    Transplantation; 1976 Oct; 22(4):337-44. PubMed ID: 62427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A terminal-labelling microcytotoxicity assay with 125I-iododeoxyuridine as a label for target cells.
    Stirrat GM
    J Immunol Methods; 1976; 12(3-4):201-18. PubMed ID: 987115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of mouse placental trophoblast to cytotoxic effector cells.
    Smith G
    J Reprod Immunol; 1983 Jan; 5(1):39-47. PubMed ID: 6834339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive method to measure PHA-induced cytotoxicity to adherent target cells using [3H]uridine as a terminal label.
    Gadiot WC; Hoedemaeker PJ; The TH
    J Immunol Methods; 1982 Nov; 55(1):85-92. PubMed ID: 6984053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic recognition and killing capacity of immune macrophages in mixed macrophage cultures (MMC).
    Gallily R
    Cell Immunol; 1975 Feb; 15(2):419-31. PubMed ID: 122917
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The popliteal node assay for graft-versus-host interaction in mice. I. Location and proliferation of donor and host cells within the popliteal node.
    Monié HJ; Everett NB
    Anat Rec; 1974 May; 179(1):19-25. PubMed ID: 4150729
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytotoxicity in graft-versus-host reaction. II. Lysis of target cells of parental genotyppe by F1 hybrid macrophages.
    Fung KY; Sabbadini E
    Transplantation; 1976 Nov; 22(5):449-54. PubMed ID: 11578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of nonspecific cytotoxicity in graft-versus-host reaction as a function of target cell type.
    Singh JN; Sabbadini E; Sehon AH
    Cell Immunol; 1973 Aug; 8(2):280-9. PubMed ID: 4146905
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro induction of tumor-specific immunity. VI: analysis of specificity of immune response by cellular competitive inhibition: limitations and advantages of the technique.
    Chism SE; Burton RC; Grail DL; Bell PM; Warner NL
    J Immunol Methods; 1977; 16(3):245-62. PubMed ID: 68981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An isotope-release assay and terminal-labeling assay for measuring cell-mediated allograft and tumor immunity to small numbers of adherent target cells.
    Tamerius JD; Garrigues HJ; Hellström I; Hellström KE
    J Immunol Methods; 1978; 22(1-2):1-22. PubMed ID: 78950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural cell-mediated immunity to lymphoma cells. I. Characteristics of effector cells in a cytostasis assay in vitro.
    Tufveson G; Riesenfeld I; Rönnblom L; Hedman A; Alm GV
    J Natl Cancer Inst; 1977 Nov; 59(5):1491-7. PubMed ID: 302867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificities in natural cell-mediated cytotoxicity by the cross-competition assay.
    Takasugi M; Koide D; Ramseyer A
    Int J Cancer; 1977 Mar; 19(3):291-7. PubMed ID: 300365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three-dimensional organotypic assay to measure target cell killing by cytotoxic T lymphocytes.
    Weigelin B; Friedl P
    Biochem Pharmacol; 2010 Dec; 80(12):2087-91. PubMed ID: 20849829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the cells that suppress the cytotoxic activity of T lymphocytes. II. Physical properties, specificity, and developmental kinetics of the inhibitory splenic non-T cell population.
    Clark DA; Phillips RA; Miller RG
    Cell Immunol; 1977 Nov; 34(1):25-37. PubMed ID: 71952
    [No Abstract]   [Full Text] [Related]  

  • 19. Education of human lymphocytes against mouse cells: specific recognition of H-2 antigens.
    Carnaud C; Fadaï-Ghotbi M; Lesavre P; Bach JF
    Eur J Immunol; 1977 Feb; 7(2):81-5. PubMed ID: 68884
    [No Abstract]   [Full Text] [Related]  

  • 20. Trypanosoma cruzi: sequence of phagocytosis and cytotoxicity by human polymorphonuclear leucocytes.
    Rimoldi MT; Cardoni RL; Olabuenaga SE; de Bracco MM
    Immunology; 1981 Apr; 42(4):521-7. PubMed ID: 7016743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.